StockData
Marker Therapeutics, Inc. logo

Marker Therapeutics, Inc. (MRKR) stock

MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 6/30
$0.84+0.01 (+0.97%)

Close on Nov 17, 2026Market cap $13.95MP/E –Yield –

Marker Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Marker Therapeutics's market cap was $15.87M on Nov 11, 2026, against $20.71M a year earlier. Over the last 5 years it ranged from $5.96M to $78.96M, with a median of $25.08M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$15.87M-36.2%
2025Dec 31, 2025$24.88M-10.1%
2024Dec 31, 2024$27.68M-42.8%
2023Dec 29, 2023$48.40M+114.4%
2022Dec 30, 2022$22.57M-71.4%
2021Dec 31, 2021$78.96M+13.5%
2020Dec 31, 2020$69.60M-47.1%
2019Dec 31, 2019$131.62M+74.4%
2018Dec 31, 2018$75.48M+83.4%
2017Dec 29, 2017$41.16M+26.4%
2016Dec 30, 2016$32.58M+66.3%
2015Dec 31, 2015$19.58M+341.4%
2014Dec 31, 2014$4.44M-98.5%
2013Dec 31, 2013$288.62M-67.4%
2012Dec 31, 2012$886.34M+24.8%
2011Dec 30, 2011$710.41M–

More Marker Therapeutics figures

See a number that looks wrong?